SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1602Monday November 20, 6:04 pm Eastern Time Press Release SOURCE: diaDexus, Inc. scaram(o)uche-11/21/2000
1601Nov. 21 /PRNewswire/ -- SGI (NYSE: SGI - news) today announced the installation nigel bates-11/21/2000
1600CV Therapeutics' Scientists Present New Data Suggesting a Novel Way To Increscaram(o)uche-11/15/2000
1599Incyte and Galapagos Announce Functional Genomics Collaboration PALO ALTO, Calibob zagorin-11/14/2000
1598Nov. 14 /PRNewswire/ -- Incyte Genomics, Inc. (Nasdaq: INCY - news), the leadingnigel bates-11/14/2000
1597Incyte and OGS Continue Proteomics Collaboration OXFORD, England and PALO ALTO,bob zagorin-11/7/2000
1596nigel, Plot thickens: siliconinvestor.com I don't suppose the technology tuck-11/6/2000
1595Nov. 2 /PRNewswire/ -- Affymetrix, Inc. (Nasdaq: AFFX - news) said that the U.K.nigel bates-11/2/2000
1594BioSpace.com and Incyte Collaborateto Expand Reach in Life Sciences and Genomicsbob zagorin-11/1/2000
1593A similarly shallow article, "A Hunt for the Gems in Genomics", lumpinRCMac-10/29/2000
1592Salomon Smith Barney's Meirav Chovav just recently came out with major reporbob zagorin-10/29/2000
1591INCY does not seem to have a good standing with analysts. I have also seen an arSpekulatius-10/29/2000
1590I don't remember reading this before. Message 14681261sim1-10/29/2000
1589Message 14632102scaram(o)uche-10/21/2000
1588"Resistance now stands at $35-1/2 which would prove hard to penetrate on ansam-10/20/2000
1587Incyte Inches Forward -- 3:00 PM EDT by Fanting Yu Biotech company Incytbob zagorin-10/20/2000
1586Richard: I see u couldn't pass this one up either. Nice to see u aboard.sam-10/19/2000
1585"THE CSCO OF GENOMICS" Incyte CEO Roy Whitfield. see radiowallstreet.greedsgd_2000-10/19/2000
1584>> University of Tubingen << I did my first postdoc in Tuebingen (Mscaram(o)uche-10/19/2000
1583nb they don't now own as much of diaDexus (20% now ??) - <i> In Septenigel bates-10/19/2000
1582Gene Therapy Rescues Brain Cells In Parkinson's Model Boston, MA -- A genebob zagorin-10/19/2000
1581Thanks, Nigel. This -- diagnostic applications -- may focus attention to (1) thscaram(o)uche-10/19/2000
1580BOSTON, Oct 18 (Reuters) - Indicators of inflammation may give doctors a way to nigel bates-10/19/2000
1579That's three initiations as buys/or upgrades in six weeks. Maybe the market tom pope-10/19/2000
1578Interesting stuff. Notice they had an analyst upgrade yesterday (FWIW). nignigel bates-10/19/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News